News

A minority of women will suffer recurrent UTIs, defined as two proven infections within six months or three within 12 months. An important start in prevention is to address hydration, recommending ...
GSK (LSE:GSK) recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and ...
The late newspaper columnist Bill Wundram of the Quad-City Times in Davenport wrote seven days a week for 31 years. Many of his columns, highlighting a wide variety of concerns in his home community, ...
Pink or orange slime that keeps coming back on your showerhead isn't just an unsightly nuisance – it could be making you ill, ...
Before UofL Health-South Hospital opened in March 2024, Bullitt County was the largest county in Kentucky without an ...
ROWING legend Sir Steve Redgrave believes the water quality in the River Thames is a “real worry” ahead of the 2025 Boat Race on Sunday. Environmental charity River Action says results ...
The Food and Drug Administration (FDA) has approved Uplizna ® (inebilizumab-cdon) for the treatment of immunoglobulin G4-related disease (IgG4-RD) in adult patients.